ATXS vs CAH · rev $706.0K vs P/E 35, rev $254.25B
Astria Therapeutics Inc (ATXS) versus Cardinal Health Inc (CAH) — a side-by-side from cached financials, not a winner call.
Astria Therapeutics Inc (ATXS) is a biotechnology company listed on US.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Latest reported ATXS revenue for 2025-09-30 was $706.0K. Net income was -$98.4M. ATXS currently screens at market cap $382.1M.
Latest reported CAH revenue for 2026-06-30 was $254.25B. Net income was $1.71B. Revenue was up 14.2% from 2025-06-30 to 2026-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
ATXS currently screens at market cap $382.1M. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Not investment advice. Open the ATXS and CAH stock pages for the full models.
Not investment advice.